We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The system was chosen for the study “due to its record of increasing the efficacy of DNA vaccines and the speed of the delivery system compared to traditional needle and syringe,” the company said. Read More
The patch has “shown the potential to transform vaccine delivery with lower dose requirements, enabling more patient-doses to be manufactured more quickly from limited vaccine supply,” the company said. Read More
The National Institutes of Health has announced a new round of contracts totaling $129.3 million to support new COVID-19 testing technologies. Read More
"The clinical experience generated during this initial study phase will be critical for the future of the therapy, as many of these patients are not good candidates for traditional surgical tricuspid valve interventions due to their poor right-heart functions," said Vinayak Bapat, the study’s co-principal investigator. Read More
The pilot study will evaluate the drug’s effect on outcomes including facilitation of infection recovery, the improvement of clinical status, and the reduction in supplemental oxygen use and progression to mechanical ventilation. Read More
“The new technologies being funded … have the potential to transform the diagnostics landscape if their promise is proven in clinical studies,” said HHS Assistant Secretary for Health Brett Giroir. Read More
The trial is the first investigational device exemption study in the U.S. for a fully resorbable device to treat blocked arteries below the knees. Read More